| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18827605 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 107 journal articles in the PubMed database | Email to a friend | | |
| Tiseo M, Capelletti M, De Palma G, et al.
Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer. [Journal Article, Research Support, Non-U.S. Gov't]
J Thorac Oncol 2008 Oct; 3(10):1104-11.
Abstract | Full Citation | Find Related Articles | | Han SW, Jeon YK, Lee KH, et al.
Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer. [JOURNAL ARTICLE]
Pharmacogenet Genomics 2007 May; 17(5):313-319.
Abstract | Full Citation | Find Related Articles | | Helfrich BA, Raben D, Varella-Garcia M, et al.
Antitumor Activity of the Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Gefitinib (ZD1839, Iressa) in Non-Small Cell Lung Cancer Cell Lines Correlates with Gene Copy Number and EGFR Mutations but not EGFR Protein Levels. [JOURNAL ARTICLE]
Clin Cancer Res 2006 Dec 1; 12(23):7117-7125.
Abstract | Full Citation | | Cappuzzo F, Hirsch FR, Rossi E, et al.
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. [Clinical Trial, Comment, Journal Article]
J Natl Cancer Inst 2005 May 4; 97(9):643-55.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ichihara S, Toyooka S, Fujiwara Y, et al.
The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer. [JOURNAL ARTICLE]
Int J Cancer 2006 Dec 27.
Abstract | Full Citation | Find Related Articles | | Taron M, Ichinose Y, Rosell R, et al.
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas. [Journal Article]
Clin Cancer Res 2005 Aug 15; 11(16):5878-85.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Nie Q, Wang Z, Zhang GC, et al.
The epidermal growth factor receptor intron1 (CA) n microsatellite polymorphism is a potential predictor of treatment outcome in patients with advanced lung cancer treated with Gefitinib. [JOURNAL ARTICLE]
Eur J Pharmacol 2007 Jun 5.
Abstract | Full Citation | | Loprevite M, Tiseo M, Chiaramondia M, et al.
Buccal Mucosa Cells as In vivo Model to Evaluate Gefitinib Activity in Patients with Advanced Non Small Cell Lung Cancer. [JOURNAL ARTICLE]
Clin Cancer Res 2007 Nov 1; 13(21):6518-6526.
Abstract | Full Citation | Find Related Articles | | Jackman DM, Yeap BY, Sequist LV, et al.
Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib. [JOURNAL ARTICLE]
Clin Cancer Res 2006 Jul 1; 12(13):3908-3914.
Abstract | Full Citation |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
